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Abstract: Four new eunicellin-based diterpenoids, krempfielins A–D (1–4), along with 
two known compounds (5 and 6) have been isolated from a soft coral Cladiella krempfi. 
The structures of the new metabolites were elucidated by extensive spectroscopic analysis 
and by comparison with spectroscopic data of related known compounds. Compounds 5 
and  6 were shown to exhibit cytotoxicity against a limited panel of cancer cell   
lines. Furthermore, compounds 2,  3,  5 and 6 were shown to exert significant in vitro  
anti-inflammatory activity against LPS-stimulated RAW264.7 macrophage cells. 
Keywords: soft coral; Cladiella krempfi; eunicellin-based diterpenoids; krempfielins; 
cytotoxic activity; anti-inflammatory activity 
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1. Introduction 
In previous studies, a series of novel secondary metabolites, including one eunicellin-based 
diterpenoid [1] and pregnane-type steroids have been isolated from the soft coral Cladiella  
krempfi [2–4]. During the course of our search for bioactive metabolites from marine invertebrates of 
Taiwanese waters, several eunicellin-type compounds also have been isolated from octocorals 
Pachyclavularia violacea [5,6], Cladiella australis [7], Cladiella hirsuta [8], Vigularia juncea [9], 
Klyxum simplex [10–14]. A related study from an Indonesian soft coral Cladiella sp. also afforded 
diterpenes of this type [15]. Recently, our investigation on the chemical constituents of the Formosan 
soft coral Cladiella krempfi yielded four new eunicellin-type metabolites, krempfielins A–D (1–4), 
along with two known eunicellin-based diterpenoids, litophynol B (5) [16] and (1R*, 2R*, 3R*, 6S*, 
7S*, 9R*, 10R*, 14R*)-3-butanoyloxycladiell-11(17)-en-6,7-diol (6) [17] (Chart 1). These compounds 
possess the more common C-2–C-9 ether linkage characteristic of the eunicellin-based diterpenoids. 
The molecular structures of these compounds, including their relative stereochemistries, were 
established by the detailed spectroscopic analysis and by comparison with related physical and spectral 
data from known compounds. The cytotoxicity of compounds 1–6 against five human tumor cell lines, 
lung adenocarcinoma (A549 and H1299), breast carcinoma (BT483), liver carcinoma (HepG2), oral 
cancer (SAS) and one human lung bronchial cell line (BEAS2B) was evaluated. The ability of 1–6 to 
inhibit the up-regulation of pro-inflammatory iNOS (inducible nitric oxide synthase) and COX-2 
(cyclooxygenase-2) proteins in LPS (lipopolysaccharide)-stimulated RAW264.7 macrophage cells was 
also evaluated.  
Chart 1. Structures of metabolites 1–6. 
  1: R1=OH
  4: R1=OMe
  2: R1=OMe, R2=OH
  3: R1=OAc, R2=OH
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O
H
H
O
R1
OH
H
H
O
AcO
1
3 5
7
9 10 11
12
13
14
15
16 17
18
19 20
HO
6
8
O
H
H
O
R1
OH
H
H
O
R2
 
2. Results and Discussion 
Krempfielin A (1) was obtained as a colorless oil. The HRESIMS (m/z 505.2777 [M + Na]
+) of 1 
established a molecular formula of C26H42O8, implying six degrees of unsaturation. The IR spectrum  
of 1 revealed the presence of hydroxyl and carbonyl groups from absorptions at 3445 and 1730 cm
−1, 
respectively. The 
13C NMR spectroscopic data of 1 exhibited 26 carbon signals (Table 1), which were 
assigned by the assistance of DEPT spectrum to six methyls (including one acetate methyl at δC 21.9), Mar. Drugs 2011, 9  
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six methylenes (including one sp
2 methylene at δC 114.9), nine methines (including five oxymethines 
at  δC 90.5, 81.9, 78.8, 77.0 and 72.9), five quaternary carbons (including two sp
2 oxygenated 
quaternary carbons at δC 172.3 and 170.5, two sp
3 oxygenated quaternary carbons at δC 86.0 and 79.3, 
and one sp
2 quaternary carbon at δC 143.7). The NMR data of 1 (Tables 1 and 2) showed the 
appearance of a terminal methylene group (δC 114.9, CH2 and 143.7, qC; δH 5.20 brs), a isopropyl 
moiety (δC 28.9, CH; 21.5, CH3; and 16.6, CH3 and δH 1.85, m, 1H; 0.97, d, 3H, J = 6.6 Hz and 0.86, 
d, 3H, J = 6.6 Hz), one n-butyrate (δC 172.3, qC; 37.3, CH2; 18.3, CH2 and 13.6, CH3; and δH 2.28, m, 
2H; 1.65, m, 2H and 0.97, t, 3H, J = 7.2 Hz) and one acetate group (δC 170.5, qC and 21.9, CH3 and  
δH 2.09, s, 3H), respectively. Analysis of HMQC correlations showed that proton signals appearing at 
δH 2.34 (1H, m), 3.30 (1H, t, J = 5.7 Hz), 3.69 (1H, s), and 4.05 (1H, dd, J = 9.3, 5.7 Hz) were correlated 
to two ring juncture methine carbons at δC 43.6 and 50.3 and two oxymethine carbons at δC 90.5 and 
81.9, respectively. This suggested the presence of a tetrahydrofuran structural unit. In addition, the  
1H–
1H COSY correlations of 1 assigned three isolated consecutive proton spin systems (Figure 1). The 
molecular framework of 1 was further established by HMBC data (Figure 1). Furthermore, H-12   
(δ 5.44) and an acetate methyl exhibited HMBC correlations to the acetate carbonyl carbon (δ 170.5), 
revealing the location of an acetate at C-12. The location of a n-butyrate at C-3 was then deduced by 
the chemical shifts of C-3 (δ  86.0) and H3-15  (δ  1.47). From the above results, the structure of 
compound 1 was shown to be highly related to that of a known compound, litophynol B (5) [16].  
Table 1. 
13C NMR data for compounds 1–4. 
 1 
a 2 
a 3 
b 4 
c 
1 43.6  (CH) 
d  45.5 (CH)  45.5 (CH)  43.9 (CH) 
2  90.5 (CH)  92.3 (CH)  92.6 (CH)  92.6 (CH) 
3  86.0 (qC)  86.1 (qC)  86.1 (qC)  85.9 (qC) 
4 34.0  (CH2) 36.2  (CH2) 35.4  (CH2) 35.4  (CH2) 
5 30.0  (CH2) 26.6  (CH2) 28.5  (CH2) 26.4  (CH2) 
6  77.0 (CH)  88.3 (CH)  82.2 (CH)  87.4 (CH) 
7  79.3 (qC)  78.7 (qC)  78.2 (qC)  78.4 (qC) 
8  78.8 (CH)  79.6 (CH)  80.1 (CH)  79.1 (CH) 
9  81.9 (CH)  81.7 (CH)  81.4 (CH)  82.5 (CH) 
10  50.3 (CH)  53.2 (CH)  53.5 (CH)  50.7 (CH) 
11  143.7 (qC)  148.4 (qC)  148.6 (qC)  143.2 (qC) 
12  72.9 (CH)  31.7 (CH2) 31.5  (CH2) 73.1  (CH) 
13 29.2  (CH2) 24.9  (CH2) 24.9  (CH2) 28.9  (CH2) 
14  37.9 (CH)  44.2 (CH)  44.1 (CH)  37.6 (CH) 
15 23.2  (CH3) 23.0  (CH3) 22.8  (CH3) 23.1  (CH3) 
16 17.8  (CH3) 18.3  (CH3) 18.4  (CH3) 18.5  (CH3) 
17 114.9  (CH2) 114.9  (CH2) 110.6  (CH2) 116.0  (CH2) 
18  28.9 (CH)  29.0 (CH)  29.0 (CH)  28.8 (CH) 
19 21.5  (CH3) 21.9  (CH3) 21.9  (CH3) 21.8  (CH3) 
20 16.6  (CH3) 15.8  (CH3) 15.5  (CH3) 16.2  (CH3) Mar. Drugs 2011, 9  
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Table 1. Cont. 
3-n-butyrate 172.3  (qC) 
37.3 (CH2) 
18.3 (CH2) 
13.6 (CH3) 
172.3 (qC) 
37.4 (CH2) 
18.3 (CH2) 
13.6 (CH3) 
172.4 (qC) 
37.4 (CH2) 
18.4 (CH2) 
13.6 (CH3) 
172.3 (qC) 
37.3 (CH2) 
18.3 (CH2) 
13.6 (CH3) 
6-OMe   56.9  (CH3)   56.8  (CH3) 
6-OAc     171.9  (qC) 
21.4 (CH3) 
 
12-OAc 170.5  (qC) 
21.9 (CH3) 
   170.3  (qC) 
21.6 (CH3) 
a Spectra recorded at 75 MHz in CDCl3; 
b Spectra recorded at 100 MHz in CDCl3; 
c Spectra 
recorded at 125 MHz in CDCl3; 
d Deduced from DEPT. 
Table 2. 
1H NMR data for compounds 1–4. 
 1 
a 2 
a 3 
b 4 
c 
1  2.34 m  2.25 m  2.22 m  2.32 m 
2  3.69 s  3.60 s  3.64 s  3.64 s 
4 
 
1.93 m;  
2.43 m 
1.76 m; 
2.66 dd (14.4, 9.0) 
1.97 m; 
2.59 dd (15.2, 8.8) 
1.84 m; 
2.55 dd (14.0, 10.0) 
5  1.50 m; 1.71 m  1.36 m; 1.63 m  1.46 m; 1.51 m  1.35 m; 1.68 m 
6  4.63 d (7.2) 
d  4.13 d (6.3)  5.72 d (4.4)  4.12 d (8.5) 
8  3.48 d (9.3)  3.54 t (9.3)  3.58 brt (9.2)  3.45 t (9.5) 
9  4.05 dd (9.3, 5.7)  3.89 dd (9.3, 6.9)  3.84 dd (9.2, 7.2)  4.09 dd (9.5, 6.5) 
10  3.30 t (5.7)  3.32 t (6.9)  3.36 t (7.2)  3.33 t (6.5) 
12  5.44 d (3.3)   2.06 m; 2.32 m  2.05 m; 2.31 m  5.46 dd (5.0, 2.5) 
13  1.50 m; 1.88 m  1.07 m; 1.75 m  1.06 m; 1.76 m  1.46 m; 1.90 m 
14  1.68 m  1.29 m  1.25 m  1.67 m 
15  1.47 s  1.41 s  1.38 s  1.46 s 
16  1.26 s  1.24 s  1.29 s  1.23 s 
17  5.20 brs  4.79 s, 4.90 s  4.79 s, 4.89 s  5.20 s, 5.21 s 
18  1.85 m  1.72 m  1.69 m  1.82 m 
19  0.97 d (6.6)  0.96 d (6.6)  0.97 d (6.8)  0.96 d (6.5) 
20  0.86 d (6.6)  0.79 d (6.6)  0.79 d (6.8)  0.85 d (6.5) 
3-n-butyrate 2.28  m 
1.65 m 
0.97 t (7.2) 
2.34 m 
1.67 m 
0.99 t (7.5) 
2.31 m, 2.34 m 
1.67 m 
0.99 t (7.2) 
2.17 m, 2.29 m 
1.59 m 
0.97 t (7.5) 
6-OMe    3.36 s    3.36 s 
6-OAc     2.09  s   
12-OAc  2.09 s      2.08 s 
a Spectra recorded at 300 MHz in CDCl3; 
b Spectra recorded at 400 MHz in CDCl3; 
c Spectra 
recorded at 500 MHz in CDCl3; 
d J values (Hz) in parentheses. 
The relative configuration of 1 was mostly confirmed to be the same as that of 5 by comparison of 
the chemical shifts of both compounds and was further confirmed by NOE correlations (Figure 2). 
Furthermore, one additional NOE correlation between H-10 with H-12 suggested that H-12 was   Mar. Drugs 2011, 9  
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β-oriented and the relative configuration of 1 was proposed as 1R*, 2R*, 3R*, 6S*, 7R*, 8S*, 9S*, 
10R*, 12S*, and 14R*. 
Figure 1. Selected 
1H−
1H COSY (▬) and HMBC (→) correlations of 1–3. 
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The HRESIMS of krempfielin B (2) exhibited a [M + Na]
+ peak at m/z 461.2881 and established a 
molecular formula of C25H42O6, appropriate with five degrees of unsaturation. By comparison of the 
1H and 
13C NMR data of 2 with those of 5, it was found that they were very similar. However, a 
methoxyl group (δH 3.36, 3H, s; δC 56.95, CH3) was observed in 2. In addition, the position of 
methoxyl group at C-6 was confirmed by the HMBC correlation of the methoxyl proton (δH 3.36) to an 
oxymethine carbon (δC 88.3, CH, C-6). A more detailed analysis of the 
1H and 
13C NMR spectroscopic 
data and correlations in the 
1H–
1H COSY and HMBC spectra led to the establishment of the gross 
structure of 2 (Figure 1). The NOESY correlations of 2 (Figure 2) also showed the stereochemistry 
similarity between compounds 2 and 5.  All of the above information suggested that 2 was the   
6-O-methyl derivative of 5. 
The molecular formula C26H42O7 with six degrees of unsaturation was assigned to krempfielin C (3) 
from its HRESIMS data (m/z 489.2829 [M + Na]
+). The NMR spectroscopic data of 3 (Tables 1 and 2) 
showed the presence of one acetoxy group (δC 171.9, qC and 21.4, CH3; and δH 2.09 s, 3H) and one  
n-butyryloxy group (δC 172.4, qC; 37.4, CH2; 18.4, CH2 and 13.6, CH3; and δH 2.34 m, 1H; 2.31 m, 
1H; 1.67 m, 2H and 0.99 t, 3H, J = 7.2 Hz). NMR data of 3 showed similarities with those of 5, except 
for the presence of an acetoxyl group at C-6 of 3 that downfielded H-6 to δH 5.72 and C-6 to δC 
82.2 ppm. These observations could be further confirmed by the correlations observed in the 2D NMR 
(including 
1H–
1H COSY, HMBC and NOESY) experiments of 3 (Figures 1 and 2). Mar. Drugs 2011, 9  
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Figure 2. Key NOESY correlations for 1–3. 
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Krempfielin D (4) was isolated as a colorless oil with a molecular formula C27H44O8 which 
possesses six units of unsaturation, as indicated by HRESIMS (m/z 519.2934). The 
1H and 
13C NMR 
spectral data of 4 (Tables 1 and 2) revealed that the structure of metabolite 4 should be similar to that 
of 1, as the NMR spectral data of 4 are almost identical with those of 1 except for the presence of a 
methoxyl group (δH 3.36, 3H, s) in 4. Also, the 
13C NMR spectrum of 4 showed the same number of 
methylene, methine, and quaternary carbons as that of 1, except for the presence of a methoxyl carbon, 
which showed a signal at δC 56.8 (qC). Furthermore, the methoxyl protons gave an HMBC cross-peak 
with an oxymethine carbon (δ 87.4, CH), indicating the presence of the methoxyl group at C-6 in 4. 
The stereochemistry of 4 was confirmed by comparison of the NMR data and NOE correlations of 
both 1 and 4. 
The cytotoxicity of the diterpenoids 1–6 against five human carcinoma cell lines A549, H1299, 
BT483, HepG2, SAS and one human normal cell line BEAS2B was evaluated by the MTT assay. It 
was found that only 5 showed activity against the proliferation of H1299 and BT483 cancer cells  
(ED50 values of 18.1 ± 1.5, and 13.2 ± 1.1 μg/mL), and 6 exhibited cytotoxicity toward A549, BT483 
and SAS cancer cell lines (ED50 values of 15.8 ± 2.0, 8.5 ± 1.0 and 14.3 ± 1.8 μg/mL), respectively. Mar. Drugs 2011, 9  
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Furthermore, 5 and 6 were found to be non-cytotoxic toward the normal cell BEAS2B. In the present 
study, the in vitro anti-inflammatory effects of compounds 1–6 were also tested by examining the 
inhibitory activity of these compounds toward the LPS-induced up-regulation of pro-inflammatory 
proteins, iNOS and COX-2 in RAW264.7 macrophage cells (Figure 3). At a concentration of 10 μM, 
compounds 2–6 were found to significantly reduce the levels of iNOS protein, relative to the control 
cells stimulated with LPS only. However, these metabolites did not effectively reduce the expression 
of COX-2 protein. 
Figure 3. Effect of compounds 1–6 on lipopolysaccharide (LPS)-induced inducible nitric 
oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2) proteins expression in 
RAW264.7 macrophage cells by immunoblot analysis. The values are mean ± SEM.   
(n  = 6). Relative intensity of the LPS alone stimulated group was taken as 100%.   
* Significantly different from LPS alone stimulated group (* P < 0.05). 
a stimulated with 
LPS; 
b stimulated with LPS in the presence of 1–6 (10 μM).  
3. Experimental Section 
3.1. General Experimental Procedures 
Optical rotations were measured on a JASCO P-1020 polarimeter. IR spectra were recorded on a 
JASCO FT/IR-4100 infrared spectrophotometer. ESIMS and HRESIMS were obtained with a Bruker 
APEX II mass spectrometer. The NMR spectra were recorded in CDCl3 either on a Varian UNITY 
INOVA-500 FT-NMR, a Varian 400MR FT-NMR or a Bruker AMX-300 FT-NMR. Silica gel (Merck, 
230–400 mesh) was used for column chromatography. Precoated silica gel plates (Merck, Kieselgel  
60 F-254, 0.2 mm) were used for analytical TLC. High performance liquid chromatography was 
performed on a Hitachi L-7100 HPLC apparatus with an ODS column (250 × 21.2 mm, 5 mm). 
3.2. Animal Material 
C. krempfi was collected by hand using scuba off the coast of Penghu islands of Taiwan in June 
2008, at a depth of 5–10 m, and stored in a freezer until extraction. A voucher sample was deposited at 
the Department of Marine Biotechnology and Resources, National Sun Yat-sen University. Mar. Drugs 2011, 9  
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3.3. Extraction and Separation 
The octocoral (1.1 kg fresh wt) was collected and freeze-dried. The freeze-dried material was 
minced and extracted exhaustively with EtOH (3 × 10 L). The EtOH extract of the frozen organism 
was partitioned between CH2Cl2 and H2O. The CH2Cl2-soluble portion (14.4 g) was subjected to 
column  chromatography on silica gel and eluted with EtOAc in n-hexane (0–100% of EtOAc, 
stepwise) and then further with MeOH in EtOAc with increasing polarity to yield 41 fractions. 
Fraction 28, eluted with n-hexane–EtOAc (1:2), was rechromatoraphed over a RP-18 open column 
using acetone–H2O (10:1) as the mobile phase to afford six subfractions (A1–A6). Subfraction A1 was 
separated by reverse phase HPLC (CH3CN–H2O, 1:1 to 2:1) to afford compounds 1 (8.3 mg),   
2 (3.5 mg), 3 (6.2 mg), 5 (12.2 mg) and 6 (21.3 mg). Subfraction A2 separated by reverse phase HPLC 
(CH3CN–H2O, 3.8:1) to afford compound 4 (5.0 mg). 
Krempfielin A (1): colorless oil; [α]D
25 −39.2 (c 0.83, CHCl3); IR (neat) νmax 3445, 2919, 1730, 
1648, 1462, 1375, 1243, 1183 and 1043 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; ESIMS 
m/z 505 [M + Na]
+; HRESIMS m/z 505.2775 [M + Na]
+ (calcd for C26H42O8Na, 505.2777).  
Krempfielin B (2): colorless oil; [α]D
25 −62.9 (c 0.35, CHCl3); IR (neat) νmax 3461, 2931, 1735, 
1645, 1456, 1370, 1251, 1174 and 1046 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; ESIMS 
m/z 461 [M + Na]
+; HRESIMS m/z 461.2881 [M + Na]
+ (calcd for C25H42O6Na, 461.2879).  
Krempfielin C (3): colorless oil; [α]D
25 −51.3 (c 0.62, CHCl3); IR (neat) νmax 3471, 2931, 1733, 
1647, 1456, 1370, 1251, 1176 and 1081 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; ESIMS 
m/z 489 [M + Na]
+; HRESIMS m/z 489.2829 [M + Na]
+ (calcd for C26H42O7Na, 489.2828).  
Krempfielin D (4): colorless oil; [α]D
25 −52.4 (c 0.5, CHCl3); IR (neat) νmax 3462, 2924, 1733, 1651, 
1456, 1372, 1240, 1176 and 1080 cm
−1; 
1H and 
13C NMR data, see Tables 1 and 2; ESIMS m/z 519  
[M + Na]
+; HRESIMS m/z 519.2934 [M + Na]
+ (calcd for C27H44O8Na, 519.2937).  
3.4. Cytotoxicity Testing 
Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays 
of compounds 1–6 were performed using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] colorimetric method [18,19].  
3.5. In Vitro Anti-Inflammatory Assay 
Macrophage (RAW264.7) cell line was purchased from ATCC. In vitro anti-inflammatory activities 
of compounds 1–6 were measured by examining the inhibition of lipopolysaccharide (LPS) induced 
upregulation of iNOS (inducible nitric oxide synthetase) and COX-2 (cyclooxygenase-2) proteins in 
macrophages cells using western blotting analysis [20,21]. 
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